Key result
Echo-estimated pulmonary artery pressure poorly agrees with RHC in dogs with MMVD.
Why the study?
Echocardiographically identified pulmonary hypertension predicts poor outcome in dogs with MMVD, but the accuracy of Doppler-estimated systolic pulmonary arterial pressure in this population was unknown.
Does echocardiographically estimated pulmonary artery pressure accurately reflect right heart catheterization measurements in dogs with myxomatous mitral valve disease?
Observational (n=20)
Blinded
Does echocardiographically estimated pulmonary artery pressure accurately reflect right heart catheterization measurements in dogs with myxomatous mitral valve disease?
Mean Difference: 0.5 (95% CI -6.5–7.5)
p-value: p=0.17
Echocardiographically estimated pulmonary artery pressure shows poor agreement with invasive right heart catheterization in dogs with MMVD, suggesting caution when interpreting these non-invasive estimates.
Noninvasive pulmonary pressure estimates require cautious interpretation in dogs with MMVD; leaves open validation against catheterization in future studies.
INTRODUCTION: Echocardiographically identified pulmonary hypertension is an independent predictor of poor outcome in dogs affected by myxomatous valvular degeneration (MMVD). Systolic pulmonary arterial pressure is routinely estimated based on its relationship with the Doppler-determined velocity of tricuspid regurgitation as defined by the simplified Bernoulli equation (sPAP_D). Experimental studies suggest that the method is imperfect, but its accuracy in dogs with MMVD is not known. ANIMALS: Twenty dogs affected by MMVD that had cardiac remodeling and measurable tricuspid regurgitation. METHODS: A flow-directed thermodilution monitoring catheter was percutaneously placed in the right external jugular vein and advanced to the main pulmonary artery. Pulmonary arterial systolic pressure was recorded (systolic pulmonary arterial pressure obtained by right heart catheterization [sPAP_C]). A second operator contemporaneously acquired tricuspid regurgitant velocity spectra to calculate sPAP_D. Each operator was blinded to the result of the other techniques. RESULTS: Technical difficulties prevented the analysis of catheterization data in two dogs. Eighteen measurement pairs were therefore used for comparison of sPAP_C and sPAP_D through correlation and Bland-Altman analysis. A statistically significant bias between sPAP_C and sPAP_D (mean difference = 0.5 mmHg; confidence interval = -6.5 mmHg, +7.5 mmHg) was not detected. The interval of agreement between the techniques was wide (-27.3 mmHg, +28.2 mmHg). A significant linear association between the two techniques was not identified (r = 0.11, p=0.17). CONCLUSION: Echocardiographically estimated pulmonary artery pressure poorly agrees with sPAP_C measurement in dogs affected by MMVD and cardiac remodeling with or without previously diagnosed congestive heart failure. In these dogs, sPAP_D could under- or over-estimate sPAP_C by more than 20 mmHg, and therefore caution should be used when interpreting sPAP_D.
No takes yet. Share an insight, caveat, or question.
Menciotti et al. (2021) conducted an observational in Myxomatous mitral valve disease (MMVD) (n=20). Echocardiographically estimated pulmonary artery pressure (sPAP_D) vs. Right heart catheterization (sPAP_C) was evaluated on Agreement between sPAP_C and sPAP_D (MD 0.5 mmHg, 95% CI -6.5 to 7.5, p=0.17). Echocardiographically estimated pulmonary artery pressure poorly agreed with right heart catheterization in dogs with MMVD (mean difference 0.5 mmHg; limits of agreement -27.3 to +28.2 mmHg).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: